Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants
Completed · Phase 1 · Has a placebo group
Conditions studied: Dose Finding Study
In brief
The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.
Key facts
- Study ID
- NCT02706834
- Run by
- Takeda
- People needed
- 36
- Starts
- 2016-03-01
- Expected to finish
- 2016-06-17
- Last updated by the study team
- 2018-10-19
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Study site — Baltimore, Maryland, United States
- Study site — Austin, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.